SEATTLE--(BUSINESS WIRE)--Sound Pharmaceuticals is pleased to announce that the pivotal Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of ...
Most patients with Meniere disease (MD) who undergo cochlear implantation (CI) in the MD-affected ear have stability or improvement of vestibular symptoms, according to a study published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results